Get the Stockscreener App
3.89
3.95%
-0.16
After Hours:
3.90
0.010
+0.26%
Briacell Therapeutics Corp stock is traded at $3.89, with a volume of 138.44K.
It is down -3.95% in the last 24 hours and down -2.75% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$4.05
Open:
$4.05
24h Volume:
138.44K
Relative Volume:
0.30
Market Cap:
$28.20M
Revenue:
-
Net Income/Loss:
$-29.96M
P/E Ratio:
-0.1408
EPS:
-27.6253
Net Cash Flow:
$-31.64M
1W Performance:
-13.94%
1M Performance:
-2.75%
6M Performance:
-64.76%
1Y Performance:
-2.99%
1-Day Range:
$3.85
$4.10
1-Week Range:
$3.85
$4.51
52-Week Range:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.89 | 29.36M | 0 | -29.96M | -31.64M | -27.63 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Buybacks Report: Does BriaCell Therapeutics Corp have a sustainable dividend2026 Action & Accurate Intraday Trade Tips - baoquankhu1.vn
Momentum Shift: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sector2026 Weekly Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Earnings Report: Should I set a stop loss on BriaCell Therapeutics Corp Equity Warrant2026 Sector Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
If You Invested $1,000 in Briacell Therapeutics Corp (BCTX) - Stock Titan
BriaCell Therapeutics Corp.: Fundamental Analysis and Financial Ratings | | CA1079303071 - marketscreener.com
Earnings Beat: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returnsDollar Strength & Reliable Intraday Trade Plans - baoquankhu1.vn
Dip Buying: Is now the right time to enter BriaCell Therapeutics Corp Equity Warrant2026 Highlights & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Portfolio Recap: Is BriaCell Therapeutics Corp a strong candidate for buy and hold2026 Chart Watch & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Catalysts: What is BriaCell Therapeutics Corp Equity Warrants debt to equity ratio2026 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Travel Stocks: What is the next catalyst for CRNTProduct Launch & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Treasury Yields: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returns2026 Macro Impact & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Outlook: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
BCTX PE Ratio & Valuation, Is BCTX Overvalued - Intellectia AI
BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeti - GuruFocus
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR - TipRanks
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference - The Manila Times
BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference - Bitget
BriaCell to Present Positive Clinical Data for Bria-IMT™ - GlobeNewswire
(BCT) Strategic Investment Guide (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp. 2026 Q2 Financial Results and Nasdaq Listing Overview - Minichart
Published on: 2026-03-12 08:04:05 - baoquankhu1.vn
Take Profit: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Buyback Activity & Daily Entry Point Trade Alerts - baoquankhu1.vn
Why did BCTX stock surge 50% today? - MSN
BriaCell (NASDAQ: BCTX) boosts cash to fund cancer trials amid higher losses - Stock Titan
BriaCell Therapeutics Corp. Files Form 8-K: Company Details, NASDAQ Ticker Symbols, and Key Disclosures (March 2026) 343637 - Minichart
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting - Yahoo Finance
BriaCell Shareholders Approve Auditors and Reelect Board - TipRanks
BriaCell (NASDAQ: BCTX) shareholders re-approve equity plan and board slate - Stock Titan
Why retail investors favor BriaCell Therapeutics Corp. stock2026 Earnings Impact & Real-Time Chart Pattern Alerts - Naître et grandir
IPO Launch: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Stock Analysis & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What sentiment indicators say about BriaCell Therapeutics Corp. Equity Warrant stock2025 Price Action Summary & Free High Return Stock Watch Alerts - Naître et grandir
Market Pulse: What is the next catalyst for BriaCell Therapeutics Corp2025 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
Why is BriaCell Therapeutics Corp stock going downQuarterly Growth Report & Short-Term High Return Ideas - baoquankhu1.vn
Merger Talk: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Volume Report & Weekly Momentum Stock Picks - baoquankhu1.vn
How To Trade (BCT) (BCT:CA) - Stock Traders Daily
Retail Trends: Does BriaCell Therapeutics Corp align with a passive investing strategy2025 Market Sentiment & Growth-Oriented Investment Plans - baoquankhu1.vn
BCT.CA Earnings History & Surprises | EPS & Revenue Results | BRIACELL THERAPEUTICS CORP (TSX:BCT) - ChartMill
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting - Investing News Network
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting - TipRanks
Aug Retail: Can BriaCell Therapeutics Corp ride the EV waveEntry Point & Smart Money Movement Alerts - baoquankhu1.vn
AI Stocks: Is Putnam Master Intermediate Income Trust stock risky to hold nowMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn
BriaCell Therapeutics: Key Catalysts on the Horizon for Investors - AD HOC NEWS
Trading (BCT) With Integrated Risk Controls (BCT:CA) - Stock Traders Daily
EPS Watch: Is BriaCell Therapeutics Corp a defensive stockEarnings Risk Summary & Smart Investment Allocation Tips - baoquankhu1.vn
BCTXZBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily
BCTXBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
Basic earnings per share (basic EPS) of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to earnings ratio of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Number of employees of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
BCTXL | BriaCell Therapeutics Corp. Warrant Institutional Ownership - Quiver Quantitative
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):